OTCPK:MDXH.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, Australia, Asia, and Latin America. More Details


Snowflake Analysis

Limited growth with imperfect balance sheet.


Similar Companies

Share Price & News

How has MedX Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MDXH.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

7.1%

MDXH.F

1.6%

US Medical Equipment

2.3%

US Market


1 Year Return

n/a

MDXH.F

19.1%

US Medical Equipment

17.2%

US Market

Return vs Industry: Insufficient data to determine how MDXH.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how MDXH.F performed against the US Market.


Shareholder returns

MDXH.FIndustryMarket
7 Day7.1%1.6%2.3%
30 Day17.1%-2.3%-4.6%
90 Dayn/a9.7%7.4%
1 Yearn/a20.1%19.1%19.8%17.2%
3 Year2.8%2.8%70.5%66.0%37.4%28.3%
5 Yearn/a145.9%127.1%83.8%63.0%

Price Volatility Vs. Market

How volatile is MedX Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MedX Health undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether MedX Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as MedX Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of MDXH.F's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through MedX Health regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is MedX Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

145.8%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MDXH.F's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if MDXH.F's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MDXH.F's revenue (145.8% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: MDXH.F's revenue (145.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MDXH.F's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has MedX Health performed over the past 5 years?

-35.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MDXH.F is currently unprofitable.

Growing Profit Margin: MDXH.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MDXH.F is unprofitable, and losses have increased over the past 5 years at a rate of 35.7% per year.

Accelerating Growth: Unable to compare MDXH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDXH.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: MDXH.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is MedX Health's financial position?


Financial Position Analysis

Short Term Liabilities: MDXH.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MDXH.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MDXH.F has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: MDXH.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MDXH.F has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: MDXH.F is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Next Steps

Dividend

What is MedX Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MDXH.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDXH.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MDXH.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDXH.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MDXH.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.6yrs

Average management tenure


CEO

Rob von der Porten

0.17

Tenure

CA$112,500

Compensation

Mr. Robert von der Porten, also known as Rob, MBA, BA, has been Chairman of the Board of MedX Health Corp. from September 18, 2018 and serves as its Director since November 29, 2013. Mr. von der Porten ser ...


CEO Compensation Analysis

Compensation vs Market: Rob's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD601.03K).

Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Robert von der Porten
Chairman0.17yrCA$112.50k0.57%
CA$ 93.3k
James Cooke
Chief Financial Officer6.83yrsCA$205.89k0.26%
CA$ 42.0k
Louie Canitano
COO & MD of Light Therapy Products6.67yrsCA$210.85k0.25%
CA$ 41.1k
Peter Holmes
Vice President of Sales13.25yrsCA$63.29kno data
Daniel Kaute
Managing Director of Europe4.5yrsno datano data
Scott Naughton
Managing Director of US Operations3.75yrsno datano data
Mike Druhan
President of Dermatological Services & Productsno datano datano data
Naman Demaghlatrous
Managing Director of EMEAno datano datano data
Christopher Freeman
Secretaryno datano datano data

5.6yrs

Average Tenure

Experienced Management: MDXH.F's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert von der Porten
Chairman0.17yrCA$112.50k0.57%
CA$ 93.3k
David Hennigar
Independent Director18.83yrsno data0.13%
CA$ 20.5k
N. Van Nest
Independent Director18.83yrsno data1.43%
CA$ 233.7k
Kenneth McKay
Independent Director18.83yrsno data0.49%
CA$ 81.0k
Eggert Stockfleth
Member of Medical Advisory Board1.92yrsno datano data
Paul Cohen
Member of Medical/Scientific Advisory Board3.33yrsno datano data
Daniel Siegel
Member of Medical Advisory Board2.33yrsno datano data
David Breukelman
Independent Director4.83yrsno datano data
Dennis Reich
Member of Medical/Scientific Advisory Board3.5yrsno datano data
Trevor Champagne
Member of Medical Advisory Board2.08yrsno datano data
Bruno Battistini
Member of Medical Advisory Board1.75yrsno datano data
Joe Walls
Member of Medical Advisory Boardno datano datano data

3.3yrs

Average Tenure

74.5yo

Average Age

Experienced Board: MDXH.F's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.6%.


Top Shareholders

Company Information

MedX Health Corp's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MedX Health Corp
  • Ticker: MDXH.F
  • Exchange: OTCPK
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$21.928m
  • Listing Market Cap: CA$16.365m
  • Shares outstanding: 175.42m
  • Website: https://www.medxhealth.com

Location

  • MedX Health Corp
  • 1495 Bonhill Road
  • Unit #1
  • Mississauga
  • Ontario
  • L5T 1M2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDXTSXV (TSX Venture Exchange)YesCommon SharesCACADFeb 2008
9MHDB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2008
MDXH.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2008

Biography

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United S ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/30 00:08
End of Day Share Price2020/09/29 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.